Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: Berner Laura

Thu, 11 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260611/26635839.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: Berner Laura

Thu, 11 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260611/26635839.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: LAPORTE KATHLEEN

Thu, 11 Jun 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260611/26635804.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: LAPORTE KATHLEEN

Thu, 11 Jun 2026 16:14:00 -0400

si-local-file:///var/storage/secattach/20260611/26635804.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: Dupont Jakob

Thu, 11 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260611/26635760.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: Dupont Jakob

Thu, 11 Jun 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260611/26635760.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: O'CALLAGHAN BRIAN

Thu, 11 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260611/26635735.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: O'CALLAGHAN BRIAN

Thu, 11 Jun 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260611/26635735.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: ONETTO NICOLE

Thu, 11 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260611/26635668.html

Form 4 Bolt Biotherapeutics, For: Jun 10 Filed by: ONETTO NICOLE

Thu, 11 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260611/26635668.html

Form 8-K Bolt Biotherapeutics, For: Jun 11

Thu, 11 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260611/26635614.html

Form 8-K Bolt Biotherapeutics, For: Jun 11

Thu, 11 Jun 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260611/26635614.html

Rodman & Renshaw Starts Bolt Biotherapeutics, Inc. (BOLT) at Buy

Thu, 28 May 2026 16:17:15 -0400

Rodman & Renshaw analyst Michael King Jr. initiates coverage on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) with a Buy rating and a price target of $22.00.

The analyst comments "We are initiating coverage of Bolt Biotherapeutics with a BUY rating and $22 price target based on the company's first-in-class Claudin 18.2 immune-stimulating antibody conjugate (ISAC) platform, a near-term 3Q26 clinical readout from BDC-4182, and an enterprise value that ascribes essentially zero worth to a pipeline of therapeutic modalities that could redefine how the immune system is directed against solid tumors."

For an analyst ratings summary and ratings history on Bolt Biotherapeutics, Inc.

Rodman & Renshaw Starts Bolt Biotherapeutics, Inc. (BOLT) at Buy

Thu, 28 May 2026 16:17:15 -0400

Rodman & Renshaw analyst Michael King Jr. initiates coverage on Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) with a Buy rating and a price target of $22.00.

For an analyst ratings summary and ratings history on Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics (BOLT) Misses Q1 EPS by 431c

Tue, 12 May 2026 17:50:10 -0400

Bolt Biotherapeutics (NASDAQ: BOLT) reported Q1 EPS of ($4.31). Revenue for the quarter came in at $30 thousand.

For earnings history and earnings-related data on Bolt Biotherapeutics (BOLT) click here.

Form 10-Q Bolt Biotherapeutics, For: Mar 31

Tue, 12 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260512/26477778.html

Form 10-Q Bolt Biotherapeutics, For: Mar 31

Tue, 12 May 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260512/26477778.html

Form 8-K Bolt Biotherapeutics, For: May 12

Tue, 12 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260512/26477692.html

Form 8-K Bolt Biotherapeutics, For: May 12

Tue, 12 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260512/26477692.html

Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update